What is the Org number of Sever Pharma Solutions AB?

Sever Pharma Solutions AB is registered with Bolagsverket / SCB under Org 5564995081.

What is the revenue of Sever Pharma Solutions AB?

Sever Pharma Solutions AB reported revenue of 712,2 mn kr in 2024.

Sever Pharma Solutions AB employs 306 people as of the latest annual report.

Fredrik Hultenius is the CEO of Sever Pharma Solutions AB, in role since 2025.

Fredrik Hultenius chairs the board of Sever Pharma Solutions AB, in role since 2025.

Sever Pharma Solutions AB's registered address is Agneslundsvägen 27.

ABActive

Org 5564995081Agneslundsvägen 27, 212 15 MalmöManufacture of pharmaceutical preparations· NACE 2120Est. 1994 · 31 years old306 employees

Actively employed in the business

Name	Role	Member since
Current (3)
FH Fredrik Hultenius Chief Executive Officer	Chief Executive Officer	2025
OC Ove Christofer Hultén Chief Auditor	Chief Auditor	2020
ES Emilie Sofia Nord Chief Auditor	Chief Auditor	2026

Former (3)


KS Kenneth Stokholm Chief Executive Officer	Chief Executive Officer	2020 – 2025
ND Nils David Segerberg Chief Executive Officer	Chief Executive Officer	2020 – 2020
SJ Sven Jakob Tenselius

Non-executive oversight

Name	Role	Member since
Current (5)
JX Jianis Xouri Board of Directors	Board of Directors	2025
CS Claes Stefan Petersson Deputy Board Member	Deputy Board Member	2025
EA Elsie Annelie Christin Fasth Board of Directors	Board of Directors	2020
FH Fredrik Hultenius Chairman	Chairman	2025
BN Bengt Niklas Fredrik Ellerström Board of Directors	Board of Directors	2025

Former (6)


KS Kenneth Stokholm Chairman	Chairman	2022 – 2025
SJ Sten Jakob Hedén Board of Directors	Board of Directors	2020 – 2025
UK Ulla Karin Kristhammar

As of last annual report

Shareholder	Type	Ownership	Votes	Since
Sever Life Sciences B.v	Company	100%	100%	0001
SPS Swedish Holdco AB	Company	100%	100%	2025

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.